GLP-1 receptors are expressed on up to 70% cerebral arterioles [18] and endothelial cells, and experimental models demonstrate that GLP-1 signaling promotes arteriolar vasodilation, improved endothelial nitric oxide signaling, and angiogenic pathways such as VEGF upregulation, all of which enhance nutrient and oxygen delivery to metabolically active brain regions [13,14]
While Ozempic can be an effective weight loss medication, its unsuitable for everyone
Feature Building companies for unmet needs July 16, 2026 Charles Craiks entrepreneurial journey shows how curiosity-driven chemistry led to multiple biotech companies, and how tools, collaboration and unmet clinical needs shape when academic discoveries move from the lab toward real-world impact
In reactive astrogliosis, astroglia cells experience cellular hypertrophy (increased size and GFAP protein expression) and hyperplasia (increased number of glial cells) 85,86
GLP-1 receptor agonists offer a promising solution for T2DM management, aiding glycemic control while addressing the weight management challenges associated with diabetes